HDA
ABBV icon

Harold Davidson & Associates’s AbbVie ABBV Stock Holding History

Harold Davidson & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.54M Buy
14,062
+656
+5% +$141K 1.53% 16
2026
Q1 		$2.92M Buy
13,406
+205
+2% +$45.5K 1.42% 19
2025
Q4 		$3.02M Buy
13,201
+2,338
+22% +$533K 1.33% 19
2025
Q3 		$2.52M Buy
10,863
+1,299
+14% +$265K 1.14% 21
2025
Q2 		$1.78M Sell
9,564
-172
-2% -$32K 1.15% 20
2025
Q1 		$2.04M Sell
9,736
-209
-2% -$40.6K 1.11% 22
2024
Q4 		$1.77M Buy
+9,945
New +$1.83M 0.85% 31

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Harold Davidson & Associates's ABBV Position: Q2 2026 in Review

Harold Davidson & Associates increased its AbbVie (ABBV) stake by 4.9% in Q2 2026, buying an estimated $141K and bringing the position to 14,062 shares worth $3.54M. The position accounts for 1.53% of the portfolio, ranked #16.

Harold Davidson & Associates first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Harold Davidson & Associates held 14,062 shares of AbbVie worth $3.54M as of Q2 2026.
  • Harold Davidson & Associates bought 656 AbbVie shares in Q2 2026, an estimated $141K.
  • AbbVie made up 1.53% of Harold Davidson & Associates's portfolio in Q2 2026, its #16 holding.
  • Harold Davidson & Associates first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Harold Davidson & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.